Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05984524 · ClinicalTrials.gov registry record · NA

Gamma-Music Based Intervention for Mild Alzheimer's Disease

A NA study of Alzheimer Disease, sponsored by Northeastern University.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT05984524 is a NA study of Alzheimer Disease that is actively recruiting participants, run by Northeastern University. The registered enrollment target is 60 participants, below the 2,751-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05984524, a NA study of Alzheimer Disease, is actively recruiting participants, sponsored by Northeastern University.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

The study will test and refine a novel brain-stimulation tool using gamma-frequency lights coupled with self-selected music for a gamma-music-based intervention for participants with mild Alzheimer's Disease. Results will yield a gamma-stimulation protocol that reliably influences brain activity (Aim 1), is adaptive, motivating and rewarding to use (Aim 2), and will generate predictions as to who might benefit the most from gamma-MBI (Aim 3). By bridging the gap between neurostimulation and behavioral intervention by combining music therapy with gamma- band neurostimulation, the present project aims to find a sustainable intervention that delays the progression of AD.

Conditions Studied

Alzheimer Disease

Interventions

  • BEHAVIORAL Gamma-Music Based Intervention

Study Locations (1)

Massachusetts

  • Northeastern University - Boston

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2022-07-01
Est. Completion 2027-06-30
Phase NA

Sponsor

Northeastern University

39 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05984524

The ClinicalTrials.gov registry entry for NCT05984524 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,751-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (98% lower). The listed sponsor is Northeastern University, which has 39 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Alzheimer Disease appearing as the primary indexed condition, and to 1 intervention - of which Gamma-Music Based Intervention is the first listed.

NCT05984524 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT05984524 about?

NCT05984524 is a clinical study titled "Gamma-Music Based Intervention for Mild Alzheimer's Disease". The study will test and refine a novel brain-stimulation tool using gamma-frequency lights coupled with self-selected music for a gamma-music-based intervention for participants with mild Alzheimer's Disease. Results will yield a gamma-stimulation protocol that reliably influences brain activity (Ai...

What is the current status of trial NCT05984524?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2022-07-01. Estimated completion is 2027-06-30.

What conditions does trial NCT05984524 study?

This clinical trial studies the following conditions: Alzheimer Disease.

What interventions are being tested in trial NCT05984524?

The interventions under investigation include: Gamma-Music Based Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT05984524?

This trial is sponsored by Northeastern University, which has 39 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05984524 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Alzheimer Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Alzheimer Disease

All registered trials for this condition

Massachusetts

All trials with a study site in Massachusetts

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.